Last reviewed · How we verify
Oral Electrolytes
Oral Electrolytes is a Small molecule drug developed by Universidad de Colima. It is currently FDA-approved.
At a glance
| Generic name | Oral Electrolytes |
|---|---|
| Sponsor | Universidad de Colima |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (PHASE2)
- A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma (PHASE1)
- POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure (PHASE2, PHASE3)
- Postpartum 8-aminoquinoline Breast Milk Study (PHASE2, PHASE3)
- Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease. (PHASE2)
- Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer (PHASE1)
- Preoperative Carbohydrate Loading in Diabetic Patients Undergoing Elective Abdominal Surgery (NA)
- Oral vs. Intravenous Hydration to Prevent Contrast-Associated Acute Kidney Injury in the ED (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Oral Electrolytes CI brief — competitive landscape report
- Oral Electrolytes updates RSS · CI watch RSS
- Universidad de Colima portfolio CI
Frequently asked questions about Oral Electrolytes
What is Oral Electrolytes?
Oral Electrolytes is a Small molecule drug developed by Universidad de Colima.
Who makes Oral Electrolytes?
Oral Electrolytes is developed and marketed by Universidad de Colima (see full Universidad de Colima pipeline at /company/universidad-de-colima).
What development phase is Oral Electrolytes in?
Oral Electrolytes is FDA-approved (marketed).
Related
- Manufacturer: Universidad de Colima — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing